To evaluate the impact of drug resistance in the zebrafish AML model, we established zebrafish embryo models by injecting AML1‐ETO with and without AP2M1, then analyzed CD41 expression using quantitative PCR. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.